State Street Corp X4 Pharmaceuticals, Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, State Street Corp holds 2,952,895 shares of XFOR stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,952,895

Previous 2,763,790 6.84%

Holding current value

$1.89 Million

Previous $1.6 Million 23.47%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.86 $102,116 - $162,630	189,105 Added 6.84%	2,952,895 $1.98 Million
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.47 $139,336 - $353,145	240,235 Added 9.52%	2,763,790 $1.6 Million
Q1 2024 May 15, 2024	BUY	$0.72 - $1.46 $68,951 - $139,818	95,766 Added 3.94%	2,523,555 $3.51 Million
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $29,989 - $48,671	49,163 Added 2.07%	2,427,789 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$1.03 - $2.02 $163,814 - $321,266	159,043 Added 7.17%	2,378,626 $2.59 Million
Q2 2023 Aug 14, 2023	BUY	$0.82 - $2.49 $1.68 Million - $5.1 Million	2,048,950 Added 1200.79%	2,219,583 $4.31 Million
Q4 2022 Feb 14, 2023	BUY	$0.69 - $2.21 $79,971 - $256,139	115,900 Added 211.76%	170,633 $168,000
Q1 2022 May 16, 2022	BUY	$1.48 - $2.58 $9,254 - $16,132	6,253 Added 12.9%	54,733 $96,000
Q2 2021 Aug 16, 2021	SELL	$6.49 - $9.56 $1.48 Million - $2.18 Million	-228,360 Reduced 82.49%	48,480 $315,000
Q1 2021 May 17, 2021	SELL	$6.63 - $10.28 $882,254 - $1.37 Million	-133,070 Reduced 32.46%	276,840 $2.38 Million
Q4 2020 Feb 16, 2021	SELL	$5.41 - $7.4 $71,282 - $97,502	-13,176 Reduced 3.11%	409,910 $2.64 Million
Q3 2020 Nov 10, 2020	BUY	$6.09 - $9.15 $17,052 - $25,620	2,800 Added 0.67%	423,086 $2.86 Million
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $1.16 Million - $1.52 Million	145,331 Added 52.86%	420,286 $3.92 Million
Q1 2020 May 11, 2020	BUY	$6.03 - $11.01 $1.66 Million - $3.03 Million	274,955 New	274,955 $2.75 Million

Others Institutions Holding XFOR

# of Institutions

103

Shares Held

99.9M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $43.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp X4 Pharmaceuticals, Inc Transaction History